A A shall be punished by a fine not exceeding 2.5 million won, and Defendant B shall be punished by a fine not exceeding three million won.

Defendant

A above.

1. Co-defendant C, an employee of Defendant B, committed each violation for the Defendant’s business as follows. A.

The violation of the Act on the Control of Narcotics, etc.(fest) C dealt with the psychotropic drugs as follows, although it is not a narcotics handler.

1) From July 11, 2019 to September 3, 2019, the psychotropic drug possession C worked as an employee at E stores operated by Kimhae-si D Co., Ltd. (actual operator A) and kept a total of 75 meters, including three square meters in size, “Covbol,” which is a psychotropic drug containing Pubane ingredients, for the purpose of selling psychotropic drugs. C possessed psychotropic drugs. 2) around July 21, 2019, around the above E stores, around July 11, 2019, around 200, sold to F, who was the customer of the above store, a psychotropic drug containing petubane ingredients, at KRW 12,00,000, the c. 200,000 Pubol-type 30, a c. 12,000,000 Pubol-type 20,000.

As a result, C traded psychotropic drugs.

(b) No person other than a pharmacy founder violating the Pharmaceutical Affairs Act shall sell or acquire medicines for the purpose of sale; and

The above corporation B shall not sell drugs or acquire drugs for the purpose of sale at the stores of E operated by the corporation B, while it is not a pharmacy founder.

1) From July 2019 to September 3, 2019, C acquired and stored drugs of class 171, class 698, such as “dicleex,” from the persons of Uzbekistan’s nationality who entered Korea for the purpose of sale to customers visiting the above stores from the above E stores. 2) around July 11, 2019, C sells medicines, around July 11, 2019.